Incidence of Medical Adhesive-Related Skin Injuries and Associated Factors After Pediatric Congenital Heart Surgery:

Jeiel Carlos Lamônica Crespo1,2,3,4,5,6,7,8, Daniela Reuter do Amaral1,2,3,4,5,6,7,8, Ticiane Carolina Gonçalves Faustino Campanili1,2,3,4,5,6,7,8

  • 1Jeiel Carlos Lamônica Crespo, Master of Science, Heart Institute, University of Sao Paulo, Sao Paulo, SP, Brazil.

Insights

Medical adhesive-related skin injuries (MARSI) affect over 60% of pediatric patients post-heart surgery. Transparent film dressings are a common cause, highlighting the need for preventative strategies.

Area of Science:

  • Pediatric Surgery
  • Intensive Care Medicine
  • Dermatology

Background:

  • Medical adhesive-related skin injuries (MARSI) are a significant concern in healthcare settings.
  • Identifying risk factors and incidence is crucial for effective prevention strategies, especially in vulnerable patient populations.

Purpose of the Study:

  • To determine the incidence and characteristics of MARSI in children undergoing congenital heart surgery.
  • To identify factors associated with the development of MARSI in this pediatric cohort.

Main Methods:

  • A prospective cohort study was conducted in a pediatric surgical intensive care unit (ICU).
  • 136 children were monitored daily for skin assessments post-operatively until MARSI onset or ICU discharge.
  • Statistical analyses included Fisher's exact test, Pearson's χ2 test, Mann-Whitney test, Brunner-Munzel test, and Welch 2-sample t test.

Main Results:

  • The incidence of MARSI was high at 60.3%, with the majority occurring by postoperative day 2.
  • Transparent film dressings were the most frequent cause of MARSI (86.6%).
  • Factors associated with MARSI included younger age, increased number of devices, lower Braden Q score, longer surgery/bypass/ventilation times, and longer ICU stay.

Conclusions:

  • The high incidence of MARSI necessitates increased clinical awareness and proactive interventions.
  • Avoiding polyurethane transparent film dressings without concurrent skin barrier products is recommended to mitigate MARSI risk.
Abstract